首页>
外国专利>
Pharmaceutical composition comprising phthalocyanine encapsulated in an Indian nanoesferas polu00cdmero and its process of preparation with control of the properties nanoparticuladas
Pharmaceutical composition comprising phthalocyanine encapsulated in an Indian nanoesferas polu00cdmero and its process of preparation with control of the properties nanoparticuladas
展开▼
机译:包含封装在印度纳米金丝桃属植物中的酞菁的药物组合物及其在控制纳米微粒特性的情况下的制备方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Pharmaceutical composition comprising ftalocinanina Indian nanoesferas encapsulated in a polu00cdmero and its process of preparation with control of nanoparticuladas properties.The present invention relates to a composition consisting of phthalocyanine indium (inPC), being a photosensitizing hydrophobic, which in the present invention is encapsulated in nanoesferas of PLGA peg with diameters less than 200 nm and movement sanquu00ednea prolonged, Destin For the treatment of oncological diseases via intravenous administration by photodynamic therapy.As well as a process for the preparation of this composition.More specifically, this invention relates to a composition for the treatment of oncological diseases, as well as other diseases not cancer caused by viruses, bacteria or fungi through hydrophobic photosensitizers are encapsulated in nanoesferas of PLGA peg with diu00e2 Meters of less than 200 nm for administration via intravenose followed by irradiation of the diseased area.For fotooxidau00e7u00e3o of biomolecules.The invention also includes the process of preparation of nanoesferas of PLGA peg containing inPC with control of nanoparticuladas properties such as size, zeta potential, encapsulation efficiency of the CPI.Recovery efficiency of nanoesferas and residual percentage of colloidal stabilizer from the understanding of the influence doos parameters involved in the preparation of the nanoesferas through a factorial design, which allows to optimize the size of the nanoesferas to lower diameters. Prior to 200 nm.
展开▼
机译:包含包封在polcodmero中的taltalocinanina Indian nanoesferas的药物组合物及其控制纳米微粒特性的制备方法。组合物本发明涉及由酞菁铟(inPC)组成的组合物,其为光敏疏水性,其在本发明中被包封Destin在直径小于200 nm的PLGA纳米钉中的运动持续时间延长,目的是通过光动力疗法通过静脉内给药来治疗肿瘤疾病。本发明涉及一种制备这种组合物的方法。将通过疏水性光敏剂治疗由病毒,细菌或真菌引起的肿瘤疾病以及其他非由病毒,细菌或真菌引起的癌症以外的疾病的组合物封装在PLGA钉的纳米胶中,直径小于200 nm,通过静脉内给药照射患处本发明还包括制备含有inPC的PLGA聚乙二醇的纳米胶的方法,该纳米胶可控制纳米颗粒的性质,例如尺寸,ζ电势,CPI的包封效率。通过对因子设计的了解来了解稳定剂的稳定性,该因子设计通过阶乘设计得以实现,从而可以将纳米Esferas的尺寸优化到较小的直径。在200 nm之前。
展开▼